Edition:
United States

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

2.10USD
3:59pm EST
Change (% chg)

$-0.12 (-5.41%)
Prev Close
$2.22
Open
$2.23
Day's High
$2.23
Day's Low
$2.09
Volume
314,882
Avg. Vol
448,766
52-wk High
$10.65
52-wk Low
$1.96

Chart for

About

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. Its primary therapeutic focus is oncology, including the treatment of chronic cancer pain. It is also developing therapeutic products for other indications,... (more)

Overall

Beta: 2.47
Market Cap(Mil.): $271.45
Shares Outstanding(Mil.): 122.28
Dividend: --
Yield (%): --

Financials

  SRNE.OQ Industry Sector
P/E (TTM): -- 86.96 36.27
EPS (TTM): -0.95 -- --
ROI: -25.49 10.17 12.64
ROE: -67.10 10.42 13.67

Earnings vs. Estimates